Barclays downgrades Universal Health Services to Equal-Weight
Barclays analyst Andrew Mok downgraded Universal Health Services from Overweight to Equal-Weight and set a price target of $179.

*this image is generated using AI for illustrative purposes only.
Barclays analyst Andrew Mok has downgraded Universal Health Services from Overweight to Equal-Weight. The firm announced a price target of $179 for the stock. The rating change reflects a revised outlook on the company's performance.
Rating and Price Target Details
The downgrade moves Universal Health Services from a higher conviction Overweight rating to a neutral Equal-Weight stance. The accompanying price target is set at $179.
| Metric | Details |
|---|---|
| Previous Rating | Overweight |
| New Rating | Equal-Weight |
| Price Target | $179 |
| Analyst | Andrew Mok |
| Firm | Barclays |
What specific factors led to the revised outlook on Universal Health Services' performance?
How might this downgrade impact investor sentiment towards the healthcare sector?
What are the potential risks or challenges Universal Health Services could face in the near term?


























